Primary outcome
After adjustment, the proportion of new diagnoses was 26.7 per 1,000 patients (95% CI [19.1, 37.3]) during the intervention period versus 26.2 per 1,000 patients (95% CI [18.8, 36.3]) during the control period (adjusted relative risk: 1.02 (95% CI [0.94, 1.11]; 